Wednesday, January 21, 2015

Prevalence of Off-Label Use of Oral Oncolytics

  1. Prevalence of Off-Label Use of Oral Oncolytics at a ...  

    jop.ascopubs.org/.../JOP.2014.001354.full
    Journal of Oncology Practice
    15 hours ago - ... with US Food and Drug Administration (FDA) –approved indications.3Any use of ... are compounded if minimal clinical evidence is available for use of adrug, ...

No comments: